Last reviewed · How we verify
leuprolide acetate FluidCrystal® injection depot — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
leuprolide acetate FluidCrystal® injection depot (leuprolide acetate FluidCrystal® injection depot) — Camurus AB.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| leuprolide acetate FluidCrystal® injection depot TARGET | leuprolide acetate FluidCrystal® injection depot | Camurus AB | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- leuprolide acetate FluidCrystal® injection depot CI watch — RSS
- leuprolide acetate FluidCrystal® injection depot CI watch — Atom
- leuprolide acetate FluidCrystal® injection depot CI watch — JSON
- leuprolide acetate FluidCrystal® injection depot alone — RSS
Cite this brief
Drug Landscape (2026). leuprolide acetate FluidCrystal® injection depot — Competitive Intelligence Brief. https://druglandscape.com/ci/leuprolide-acetate-fluidcrystal-injection-depot. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab